CalciMedica, Inc. (CALC)

CalciMedica Statistics

Total Valuation

CalciMedica has a market cap or net worth of $61.53 million. The enterprise value is $56.34 million.

Market Cap	61.53M
Enterprise Value	56.34M

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

CalciMedica has 14.41 million shares outstanding. The number of shares has increased by 51.38% in one year.

Current Share Class	14.41M
Shares Outstanding	14.41M
Shares Change (YoY)	+51.38%
Shares Change (QoQ)	+0.54%
Owned by Insiders (%)	11.68%
Owned by Institutions (%)	20.87%
Float	6.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.04

Current Ratio	4.04
Quick Ratio	3.83
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-18.66

Financial Efficiency

Return on equity (ROE) is -526.36% and return on invested capital (ROIC) is -176.28%.

Return on Equity (ROE)	-526.36%
Return on Assets (ROA)	-100.03%
Return on Invested Capital (ROIC)	-176.28%
Return on Capital Employed (ROCE)	-221.76%
Revenue Per Employee	n/a
Profits Per Employee	-$1.65M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.09% in the last 52 weeks. The beta is 1.39, so CalciMedica's price volatility has been higher than the market average.

Beta (5Y)	1.39
52-Week Price Change	+22.09%
50-Day Moving Average	3.21
200-Day Moving Average	2.48
Relative Strength Index (RSI)	71.91
Average Volume (20 Days)	91,428

Short Selling Information

The latest short interest is 52,651, so 0.37% of the outstanding shares have been sold short.

Short Interest	52,651
Short Previous Month	55,734
Short % of Shares Out	0.37%
Short % of Float	0.79%
Short Ratio (days to cover)	1.88

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-24.91M
Pretax Income	-23.06M
Net Income	-23.06M
EBITDA	-24.85M
EBIT	-24.91M
Earnings Per Share (EPS)	-$1.61

Balance Sheet

The company has $14.08 million in cash and $8.90 million in debt, giving a net cash position of $5.18 million or $0.36 per share.

Cash & Cash Equivalents	14.08M
Total Debt	8.90M
Net Cash	5.18M
Net Cash Per Share	$0.36
Equity (Book Value)	-268,000
Book Value Per Share	-0.02
Working Capital	11.17M

Cash Flow

In the last 12 months, operating cash flow was -$21.30 million and capital expenditures -$24,000, giving a free cash flow of -$21.32 million.

Operating Cash Flow	-21.30M
Capital Expenditures	-24,000
Free Cash Flow	-21.32M
FCF Per Share	-$1.48

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CalciMedica does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-51.38%
Shareholder Yield	-51.38%
Earnings Yield	-37.48%
FCF Yield	-34.65%

Analyst Forecast

The average price target for CalciMedica is $14.50, which is 245.24% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.50
Price Target Difference	245.24%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1